Seeking Alpha

Watson Pharmaceuticals (WPI +1.3%) is on track to announce a deal to buy Swiss-based Actavis for...

Watson Pharmaceuticals (WPI +1.3%) is on track to announce a deal to buy Swiss-based Actavis for ~$6B by the end of April, creating one of the world's biggest producers of generic drugs, Reuters reports. Watson believes a move would help it compete more effectively against rivals like Teva and Novartis unit Sandoz.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector